Mechanism of Endothelium-Dependent Vasodilation Induced by a Proanthocyanidin-Rich Fraction from Ouratea semiserrata

 

 Buy Article Permissions and Reprints

Abstract

The vasodilator effects of Ouratea semiserrata stem hydroethanolic extract (OSE) and its ethyl acetate fraction (OSR) were evaluated in endothelium-intact aortic rings. OSR produced a more potent vasodilatation (IC₅₀ = 3.5 ± 0.8 μg/ml) than OSE (IC₅₀ > 30 μg/ml). OSR also presented a higher content of total proanthocyanidins (21.8 ± 1.5 %) in comparison to OSE (6.5 ± 0.4 %), suggesting that compounds of this class play a role in the vasorelaxing activity. The vasodilatation mechanism of OSR was further investigated. In endothelium-intact aortic rings, its vasorelaxing effect was completely abolished by L-NAME (300 μM), a nitric oxide (NO) synthase inhibitor, but not by a muscarinic antagonist (atropine, 1 μM) nor by a cyclo-oxygenase inhibitor (indomethacin, 10 μM). The OSR vasodilator effect was completely abolished in endothelium-denuded vessels. Furthermore, OSR did not change the vasodilatation produced by SIN-1, an NO donor, in endothelium-denuded vessels. These findings led us to conclude that OSR, a proanthocyanidin rich fraction of O. semiserrata, induces vasodilatation by a mechanism dependent on endothelium-derived factors, likely NO.

References

• 1 Corrêa M P. Dicionário de Plantas Úteis do Brasil e das Exóticas Cultivadas. Vol. 1 - 6 Rio de Janeiro; J Di Giorgio 1974
  Google Scholar
• 2 Braga F C, Wagner H, Lombardi J A, Oliveira A B. Screening the Brazilian flora for antihypertensive plant species for in vitro angiotensin-I-converting enzyme-inhibiting activity.  Phytomedicine. 2000;  245 245-50
  PubMedGoogle Scholar
• 3 Velandia J R, De Carvalho M G, Braz-Filho R. Novel trichloro- and tetrachloroisoflavones isolated from Ouratea semiserrata .  Nat Prod Lett. 1998;  12 191-8
  PubMedGoogle Scholar
• 4 Delle Monache F, D’Albuquerque I L, Marini-Bettolo G B. Su di una nuova proantocianidina dimera da Ouratea .  Ann Chim. 1967;  57 1364-71
  PubMedGoogle Scholar
• 5 Delle Monache F, Ferrari F, D’Albuquerque I L, Marini-Bettolo G B. Sterechimica delle proantocianidine da Ouratea sp. (Ochnaceae).  Farmaco. 1970;  25 96-105
  PubMedGoogle Scholar
• 6 Hertog M GL, Feskens E JM, Hollman P CH, Katan M B, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study.  Lancet. 1993;  342 1007-11
  CrossrefPubMedGoogle Scholar
• 7 Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study.  Br Med J. 1996;  312 478-81
  PubMedGoogle Scholar
• 8 Muldoon F M, Kritchevsky S B. Flavonoids and heart disease.  Br Med J. 1996;  312 458-9
  PubMedGoogle Scholar
• 9 Duarte J, Vizcaíno F P, Utrilla P, Jiménez J, Tamargo J, Zarzuelo A. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships.  Gen Pharmacol. 1993;  24 857-62
  CrossrefPubMedGoogle Scholar
• 10 Herrera M D, Zarzuelo A, Jiménez J, Marhuenda E, Duarte J. Effects of flavonoids on rat aortic smooth musckle contractility: structure-activity relationships.  Gen Pharmacol. 1996;  27 273-7
  CrossrefPubMedGoogle Scholar
• 11 Fitzpatrick D F, Hirschfield S L, Coffey R G. Endothelium-dependent vasorelaxing activity of wine and other grape products.  Am J Physiol. 1993;  65 774-8
  PubMedGoogle Scholar
• 12 Anbriambeloson E, Magnier C, Haan-Archipoff G, Lobstein A, Anton R, Beretz A, Stoclet J C. Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta.  J Nutr. 1998;  128 2324-33
  PubMedGoogle Scholar
• 13 Lemos V S, Freitas M R, Muller B, Lino Y D, Queiroga C EG, Côrtes S F. Dioclein, a new nitric oxide- and endothlium-dependent vasodilator flavonoid.  Eur J Pharmacol. 1999;  386 41-6
  CrossrefPubMedGoogle Scholar
• 14 Lüscher T F. The endothelium in hypertension: bystander, target or mediator?.  J Hypertens. 1994;  12 S105-116
  PubMedGoogle Scholar
• 15 Vanhoutte P M, Boulanger C M. Endothlium-dependent responses in hypertension.  Hypertens Res. 1995;  18 87-98
  CrossrefPubMedGoogle Scholar
• 16 Hiermann A, Kartnig T h, Azzam S. Ein Beitrag zur quantitativen Bestimmung der Procyanidine in Crataegus .  Sci Pharm. 1986;  54 331-7
  PubMedGoogle Scholar
• 17 Middleton E, Kandaswami C, Theoharides T C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.  Pharmacol Rev. 2000;  52 673-751
  PubMedGoogle Scholar
• 18 Packer L, Rimbach G, Virgili F. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol.  Free Rad Biology Med. 1999;  27 704-24
  CrossrefPubMedGoogle Scholar
• 19 Mombouli J V, Vanhoutte P M. Endothelial dysfunction: from physiology to therapy.  J. Mol. Cell. Cardiol.. 1999;  31 61-74
  CrossrefPubMedGoogle Scholar
• 20 Moncada S, Palmer R MJ, Higgs E A. Nitric oxide: physiology, pathophysiology, and pharmacology.  Pharmacol Rev. 1991;  43 109-42
  PubMedGoogle Scholar
• 21 Busse R ., Fleming I. Endothelial dysfunction in atherosclerosis.  J Vasc Res. 1996;  33 181-94
  CrossrefPubMedGoogle Scholar
• 22 Rice-Evans C A, Miller N J, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids.  Free Rad Biol Med. 1996;  20 933-56
  CrossrefPubMedGoogle Scholar
• 23 Andriantsitohaina R, Andriambeloson E, Stoclet J C. Pharmacological approaches of endothelial nitric oxide-dependent vasorelaxation induced by polyphenols from plant extracts.  Methods Enzymol. 1999;  301 522-32
  PubMedGoogle Scholar

Fernão Castro Braga

Faculdade de Farmácia da UFMG

Av. Olegário Maciel 2360

CEP 30.180-112


Belo Horizonte

Brazil

Phone: +55 31 3339-7675

Fax: +55 31 3339-7666

Email: fernao@dedalus.lcc.ufmg.br